{"transactions":[{"id":747885,"issuer":{"id":1723,"kind":"organization","name":"Stoke Therapeutics, Inc.","symbol":"STOK"},"owners":[{"id":40913,"kind":"person","name":"Smith Julie","position":1,"cik":"0001557928","reported_name":"Smith Julie","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Option (Right to Buy)","published_at":"2026-06-05T20:31:41.000Z","date":"2026-06-03","kind":"grant","planned":false,"acquired":true,"shares":17786,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option shall vest in full on the earlier of:  (i) June 3, 2027 or (ii) the date of the issuer's next annual meeting of its stockholders, subject to the reporting person's continued service to the issuer on the vesting date."}],"balance_after":17786,"derivative":{"exercise_price":29.46,"expiration_date":"2036-06-02","underlying":"Common Stock","underlying_shares":17786},"source":{"system":"sec-edgar","filing":"0001557928-26-000002","document":"form4-06052026_080637.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1623526/000155792826000002/form4-06052026_080637.xml","form_type":"4"}},{"id":759300,"issuer":{"id":3386,"kind":"organization","name":"EXELIXIS, INC."},"owners":[{"id":40913,"kind":"person","name":"Smith Julie","position":1,"cik":"0001557928","reported_name":"Smith Julie","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-05-29T21:43:35.000Z","date":"2026-05-27","kind":"grant","planned":false,"acquired":true,"shares":8367,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock units (\"RSUs\") granted to the Reporting Person on the Transaction Date pursuant to the Exelixis, Inc. 2017 Equity Incentive Plan. Each RSU is the economic equivalent of\none share of Exelixis, Inc. common stock (\"Common Stock\"). The RSUs will vest as to 100% of the shares subject to the RSU award on May 27, 2027, subject to the Reporting Person's continuous\nservice through that date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 8,367 shares of Common Stock that will be issued to the Reporting Person upon vesting of RSUs."}],"balance_after":28957,"source":{"system":"sec-edgar","filing":"0000939767-26-000080","document":"wk-form4_1780091013.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/939767/000093976726000080/wk-form4_1780091013.xml","form_type":"4"}},{"id":894485,"issuer":{"id":3386,"kind":"organization","name":"EXELIXIS, INC."},"owners":[{"id":40913,"kind":"person","name":"Smith Julie","position":1,"cik":"0001557928","reported_name":"Smith Julie","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option (right to buy)","published_at":"2026-02-20T00:18:36.000Z","date":"2026-02-18","kind":"exercise","planned":false,"acquired":false,"shares":20030,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The option, representing the right to purchase a total of 20,030 shares of Common Stock, became fully exercisable on May 31, 2024."}],"balance_after":0,"derivative":{"exercise_price":21.69,"exercise_date":"2024-05-31","expiration_date":"2031-05-30","underlying":"Common Stock","underlying_shares":20030},"source":{"system":"sec-edgar","filing":"0000939767-26-000029","document":"wk-form4_1771546714.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/939767/000093976726000029/wk-form4_1771546714.xml","form_type":"4"}},{"id":894484,"issuer":{"id":3386,"kind":"organization","name":"EXELIXIS, INC."},"owners":[{"id":40913,"kind":"person","name":"Smith Julie","position":1,"cik":"0001557928","reported_name":"Smith Julie","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option (right to buy)","published_at":"2026-02-20T00:18:36.000Z","date":"2026-02-18","kind":"exercise","planned":false,"acquired":false,"shares":44087,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The option, representing the right to purchase a total of 44,087 shares of Common Stock, became fully exercisable on June 1, 2023."}],"balance_after":0,"derivative":{"exercise_price":19.39,"exercise_date":"2023-06-01","expiration_date":"2030-05-31","underlying":"Common Stock","underlying_shares":44087},"source":{"system":"sec-edgar","filing":"0000939767-26-000029","document":"wk-form4_1771546714.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/939767/000093976726000029/wk-form4_1771546714.xml","form_type":"4"}},{"id":894483,"issuer":{"id":3386,"kind":"organization","name":"EXELIXIS, INC."},"owners":[{"id":40913,"kind":"person","name":"Smith Julie","position":1,"cik":"0001557928","reported_name":"Smith Julie","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option (right to buy)","published_at":"2026-02-20T00:18:36.000Z","date":"2026-02-17","kind":"exercise","planned":false,"acquired":false,"shares":42422,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option, representing the right to purchase a total of 42,422 shares of Common Stock, became fully exercisable on May 26, 2022."}],"balance_after":0,"derivative":{"exercise_price":18.19,"exercise_date":"2022-05-26","expiration_date":"2029-05-25","underlying":"Common Stock","underlying_shares":42422},"source":{"system":"sec-edgar","filing":"0000939767-26-000029","document":"wk-form4_1771546714.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/939767/000093976726000029/wk-form4_1771546714.xml","form_type":"4"}},{"id":894482,"issuer":{"id":3386,"kind":"organization","name":"EXELIXIS, INC."},"owners":[{"id":40913,"kind":"person","name":"Smith Julie","position":1,"cik":"0001557928","reported_name":"Smith Julie","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-02-20T00:18:36.000Z","date":"2026-02-18","kind":"sale","planned":false,"acquired":false,"shares":20030,"price":44.3,"value":887329.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 9,812 shares of Exelixis, Inc. common stock (\"Common Stock\") that will be issued to the Reporting Person upon vesting of restricted stock units (\"RSUs\"). Each RSU is the economic equivalent of one share of Common Stock."}],"balance_after":20590,"source":{"system":"sec-edgar","filing":"0000939767-26-000029","document":"wk-form4_1771546714.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/939767/000093976726000029/wk-form4_1771546714.xml","form_type":"4"}},{"id":894481,"issuer":{"id":3386,"kind":"organization","name":"EXELIXIS, INC."},"owners":[{"id":40913,"kind":"person","name":"Smith Julie","position":1,"cik":"0001557928","reported_name":"Smith Julie","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-02-20T00:18:36.000Z","date":"2026-02-18","kind":"exercise","planned":false,"acquired":true,"shares":20030,"price":21.69,"value":434450.7,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 9,812 shares of Exelixis, Inc. common stock (\"Common Stock\") that will be issued to the Reporting Person upon vesting of restricted stock units (\"RSUs\"). Each RSU is the economic equivalent of one share of Common Stock."}],"balance_after":40620,"source":{"system":"sec-edgar","filing":"0000939767-26-000029","document":"wk-form4_1771546714.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/939767/000093976726000029/wk-form4_1771546714.xml","form_type":"4"}},{"id":894480,"issuer":{"id":3386,"kind":"organization","name":"EXELIXIS, INC."},"owners":[{"id":40913,"kind":"person","name":"Smith Julie","position":1,"cik":"0001557928","reported_name":"Smith Julie","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-02-20T00:18:36.000Z","date":"2026-02-18","kind":"sale","planned":false,"acquired":false,"shares":44087,"price":44.5,"value":1961871.5,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 9,812 shares of Exelixis, Inc. common stock (\"Common Stock\") that will be issued to the Reporting Person upon vesting of restricted stock units (\"RSUs\"). Each RSU is the economic equivalent of one share of Common Stock."}],"balance_after":20590,"source":{"system":"sec-edgar","filing":"0000939767-26-000029","document":"wk-form4_1771546714.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/939767/000093976726000029/wk-form4_1771546714.xml","form_type":"4"}},{"id":894479,"issuer":{"id":3386,"kind":"organization","name":"EXELIXIS, INC."},"owners":[{"id":40913,"kind":"person","name":"Smith Julie","position":1,"cik":"0001557928","reported_name":"Smith Julie","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-02-20T00:18:36.000Z","date":"2026-02-18","kind":"exercise","planned":false,"acquired":true,"shares":44087,"price":19.39,"value":854846.93,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 9,812 shares of Exelixis, Inc. common stock (\"Common Stock\") that will be issued to the Reporting Person upon vesting of restricted stock units (\"RSUs\"). Each RSU is the economic equivalent of one share of Common Stock."}],"balance_after":64677,"source":{"system":"sec-edgar","filing":"0000939767-26-000029","document":"wk-form4_1771546714.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/939767/000093976726000029/wk-form4_1771546714.xml","form_type":"4"}},{"id":894478,"issuer":{"id":3386,"kind":"organization","name":"EXELIXIS, INC."},"owners":[{"id":40913,"kind":"person","name":"Smith Julie","position":1,"cik":"0001557928","reported_name":"Smith Julie","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-02-20T00:18:36.000Z","date":"2026-02-17","kind":"sale","planned":false,"acquired":false,"shares":42422,"price":43.33,"value":1838145.26,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $44.30 to $44.44. Reporting Person undertakes to provide Exelixis, Inc., any security holder of Exelixis, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote 2 to this Form 4."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 9,812 shares of Exelixis, Inc. common stock (\"Common Stock\") that will be issued to the Reporting Person upon vesting of restricted stock units (\"RSUs\"). Each RSU is the economic equivalent of one share of Common Stock."}],"balance_after":20590,"source":{"system":"sec-edgar","filing":"0000939767-26-000029","document":"wk-form4_1771546714.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/939767/000093976726000029/wk-form4_1771546714.xml","form_type":"4"}},{"id":894477,"issuer":{"id":3386,"kind":"organization","name":"EXELIXIS, INC."},"owners":[{"id":40913,"kind":"person","name":"Smith Julie","position":1,"cik":"0001557928","reported_name":"Smith Julie","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-02-20T00:18:36.000Z","date":"2026-02-17","kind":"exercise","planned":false,"acquired":true,"shares":42422,"price":18.19,"value":771656.18,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 9,812 shares of Exelixis, Inc. common stock (\"Common Stock\") that will be issued to the Reporting Person upon vesting of restricted stock units (\"RSUs\"). Each RSU is the economic equivalent of one share of Common Stock."}],"balance_after":63012,"source":{"system":"sec-edgar","filing":"0000939767-26-000029","document":"wk-form4_1771546714.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/939767/000093976726000029/wk-form4_1771546714.xml","form_type":"4"}},{"id":1122853,"issuer":{"id":1723,"kind":"organization","name":"Stoke Therapeutics, Inc.","symbol":"STOK"},"owners":[{"id":40913,"kind":"person","name":"Smith Julie","position":1,"cik":"0001557928","reported_name":"Smith Julie","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Option (Right to Buy)","published_at":"2025-06-05T00:38:05.000Z","date":"2025-06-03","kind":"grant","planned":false,"acquired":true,"shares":29747,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option shall vest in full on the earlier of:  (i) June 3, 2026 or (ii) the date of the issuer's next annual meeting of its stockholders, subject to the reporting person's continued service to the issuer on the vesting date."}],"balance_after":29747,"derivative":{"exercise_price":10.9,"expiration_date":"2035-06-02","underlying":"Common Stock","underlying_shares":29747},"source":{"system":"sec-edgar","filing":"0001415889-25-015702","document":"form4-06052025_120602.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1623526/000141588925015702/form4-06052025_120602.xml","form_type":"4"}},{"id":1129775,"issuer":{"id":3386,"kind":"organization","name":"EXELIXIS, INC."},"owners":[{"id":40913,"kind":"person","name":"Smith Julie","position":1,"cik":"0001557928","reported_name":"Smith Julie","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-05-30T23:12:12.000Z","date":"2025-05-29","kind":"grant","planned":false,"acquired":true,"shares":9812,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock units (\"RSUs\") granted to the Reporting Person on the Transaction Date pursuant to the Exelixis, Inc. 2017 Equity Incentive Plan. Each RSU is the economic equivalent of one share of Exelixis, Inc. common stock (\"Common Stock\").  The RSUs will vest as to 100% of the shares subject to the RSU award on May 29, 2026, subject to the Reporting Person's continuous service through that date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 19,827 shares of Common Stock that will be issued to the Reporting Person upon vesting of RSUs."}],"balance_after":20590,"source":{"system":"sec-edgar","filing":"0000939767-25-000086","document":"wk-form4_1748646713.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/939767/000093976725000086/wk-form4_1748646713.xml","form_type":"4"}},{"id":1239356,"issuer":{"id":3386,"kind":"organization","name":"EXELIXIS, INC."},"owners":[{"id":40913,"kind":"person","name":"Smith Julie","position":1,"cik":"0001557928","reported_name":"Smith Julie","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option (right to buy)","published_at":"2025-03-01T01:35:48.000Z","date":"2025-02-28","kind":"exercise","planned":false,"acquired":false,"shares":19294,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The option, representing the right to purchase a total of 42,641 shares of Common Stock, became fully exercisable on May 23, 2019."}],"balance_after":0,"derivative":{"exercise_price":19.77,"exercise_date":"2019-05-23","expiration_date":"2026-05-22","underlying":"Common Stock","underlying_shares":19294},"source":{"system":"sec-edgar","filing":"0000939767-25-000045","document":"wk-form4_1740792942.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/939767/000093976725000045/wk-form4_1740792942.xml","form_type":"4"}},{"id":1239355,"issuer":{"id":3386,"kind":"organization","name":"EXELIXIS, INC."},"owners":[{"id":40913,"kind":"person","name":"Smith Julie","position":1,"cik":"0001557928","reported_name":"Smith Julie","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option (right to buy)","published_at":"2025-03-01T01:35:48.000Z","date":"2025-02-27","kind":"exercise","planned":false,"acquired":false,"shares":23347,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The option, representing the right to purchase a total of 42,641 shares of Common Stock, became fully exercisable on May 23, 2019."}],"balance_after":19294,"derivative":{"exercise_price":19.77,"exercise_date":"2019-05-23","expiration_date":"2026-05-22","underlying":"Common Stock","underlying_shares":23347},"source":{"system":"sec-edgar","filing":"0000939767-25-000045","document":"wk-form4_1740792942.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/939767/000093976725000045/wk-form4_1740792942.xml","form_type":"4"}},{"id":1239354,"issuer":{"id":3386,"kind":"organization","name":"EXELIXIS, INC."},"owners":[{"id":40913,"kind":"person","name":"Smith Julie","position":1,"cik":"0001557928","reported_name":"Smith Julie","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option (right to buy)","published_at":"2025-03-01T01:35:48.000Z","date":"2025-02-27","kind":"exercise","planned":false,"acquired":false,"shares":31167,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option, representing the right to purchase a total of 31,167 shares of Common Stock, became fully exercisable on May 24, 2018."}],"balance_after":0,"derivative":{"exercise_price":20.5,"exercise_date":"2018-05-24","expiration_date":"2025-05-23","underlying":"Common Stock","underlying_shares":31167},"source":{"system":"sec-edgar","filing":"0000939767-25-000045","document":"wk-form4_1740792942.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/939767/000093976725000045/wk-form4_1740792942.xml","form_type":"4"}},{"id":1239353,"issuer":{"id":3386,"kind":"organization","name":"EXELIXIS, INC."},"owners":[{"id":40913,"kind":"person","name":"Smith Julie","position":1,"cik":"0001557928","reported_name":"Smith Julie","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-03-01T01:35:48.000Z","date":"2025-02-28","kind":"sale","planned":false,"acquired":false,"shares":19294,"price":37.62,"value":725840.28,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 10,015 shares of Exelixis, Inc. common stock (\"Common Stock\") that will be issued to the Reporting Person upon vesting of restricted stock units (\"RSUs\"). Each RSU is the economic\nequivalent of one share of Common Stock."}],"balance_after":10778,"source":{"system":"sec-edgar","filing":"0000939767-25-000045","document":"wk-form4_1740792942.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/939767/000093976725000045/wk-form4_1740792942.xml","form_type":"4"}},{"id":1239352,"issuer":{"id":3386,"kind":"organization","name":"EXELIXIS, INC."},"owners":[{"id":40913,"kind":"person","name":"Smith Julie","position":1,"cik":"0001557928","reported_name":"Smith Julie","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-03-01T01:35:48.000Z","date":"2025-02-28","kind":"exercise","planned":false,"acquired":true,"shares":19294,"price":19.77,"value":381442.38,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 10,015 shares of Exelixis, Inc. common stock (\"Common Stock\") that will be issued to the Reporting Person upon vesting of restricted stock units (\"RSUs\"). Each RSU is the economic\nequivalent of one share of Common Stock."}],"balance_after":30072,"source":{"system":"sec-edgar","filing":"0000939767-25-000045","document":"wk-form4_1740792942.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/939767/000093976725000045/wk-form4_1740792942.xml","form_type":"4"}},{"id":1239351,"issuer":{"id":3386,"kind":"organization","name":"EXELIXIS, INC."},"owners":[{"id":40913,"kind":"person","name":"Smith Julie","position":1,"cik":"0001557928","reported_name":"Smith Julie","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-03-01T01:35:48.000Z","date":"2025-02-27","kind":"sale","planned":false,"acquired":false,"shares":54514,"price":38.13,"value":2078618.82,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $37.75 to $38.37. Reporting Person undertakes to provide Exelixis, Inc., any security\nholder of Exelixis, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in\nfootnote 2 to this Form 4."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 10,015 shares of Exelixis, Inc. common stock (\"Common Stock\") that will be issued to the Reporting Person upon vesting of restricted stock units (\"RSUs\"). Each RSU is the economic\nequivalent of one share of Common Stock."}],"balance_after":10778,"source":{"system":"sec-edgar","filing":"0000939767-25-000045","document":"wk-form4_1740792942.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/939767/000093976725000045/wk-form4_1740792942.xml","form_type":"4"}},{"id":1239350,"issuer":{"id":3386,"kind":"organization","name":"EXELIXIS, INC."},"owners":[{"id":40913,"kind":"person","name":"Smith Julie","position":1,"cik":"0001557928","reported_name":"Smith Julie","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-03-01T01:35:48.000Z","date":"2025-02-27","kind":"exercise","planned":false,"acquired":true,"shares":23347,"price":19.77,"value":461570.19,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 10,015 shares of Exelixis, Inc. common stock (\"Common Stock\") that will be issued to the Reporting Person upon vesting of restricted stock units (\"RSUs\"). Each RSU is the economic\nequivalent of one share of Common Stock."}],"balance_after":65292,"source":{"system":"sec-edgar","filing":"0000939767-25-000045","document":"wk-form4_1740792942.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/939767/000093976725000045/wk-form4_1740792942.xml","form_type":"4"}},{"id":1239349,"issuer":{"id":3386,"kind":"organization","name":"EXELIXIS, INC."},"owners":[{"id":40913,"kind":"person","name":"Smith Julie","position":1,"cik":"0001557928","reported_name":"Smith Julie","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-03-01T01:35:48.000Z","date":"2025-02-27","kind":"exercise","planned":false,"acquired":true,"shares":31167,"price":20.5,"value":638923.5,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 10,015 shares of Exelixis, Inc. common stock (\"Common Stock\") that will be issued to the Reporting Person upon vesting of restricted stock units (\"RSUs\"). Each RSU is the economic\nequivalent of one share of Common Stock."}],"balance_after":41945,"source":{"system":"sec-edgar","filing":"0000939767-25-000045","document":"wk-form4_1740792942.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/939767/000093976725000045/wk-form4_1740792942.xml","form_type":"4"}},{"id":1432921,"issuer":{"id":3386,"kind":"organization","name":"EXELIXIS, INC."},"owners":[{"id":40913,"kind":"person","name":"Smith Julie","position":1,"cik":"0001557928","reported_name":"Smith Julie","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-08-16T00:18:41.000Z","date":"2024-08-13","kind":"other","planned":false,"acquired":false,"shares":4682,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects transfer of 4,682 shares to ex-spouse pursuant to a settlement agreement."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 10,015 shares of Exelixis, Inc. common stock that will be issued to the Reporting Person upon vesting of restricted stock units (\"RSUs\"). Each RSU is the economic equivalent of one share of Exelixis, Inc. common stock."}],"balance_after":10778,"source":{"system":"sec-edgar","filing":"0000939767-24-000129","document":"wk-form4_1723767514.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/939767/000093976724000129/wk-form4_1723767514.xml","form_type":"4"}},{"id":1486724,"issuer":{"id":1723,"kind":"organization","name":"Stoke Therapeutics, Inc.","symbol":"STOK"},"owners":[{"id":40913,"kind":"person","name":"Smith Julie","position":1,"cik":"0001557928","reported_name":"Smith Julie","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Option (Right to Buy)","published_at":"2024-06-07T20:27:32.000Z","date":"2024-06-05","kind":"grant","planned":false,"acquired":true,"shares":7639,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option shall vest in full on the earlier of:  (i) June 5, 2025 or (ii) the date of the issuer's next annual meeting of its stockholders, subject to the reporting person's continued service to the issuer on the vesting date."}],"balance_after":7639,"derivative":{"exercise_price":16.41,"expiration_date":"2034-06-04","underlying":"Common Stock","underlying_shares":7639},"source":{"system":"sec-edgar","filing":"0001415889-24-015974","document":"form4-06072024_080629.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1623526/000141588924015974/form4-06072024_080629.xml","form_type":"4"}},{"id":1493556,"issuer":{"id":3386,"kind":"organization","name":"EXELIXIS, INC."},"owners":[{"id":40913,"kind":"person","name":"Smith Julie","position":1,"cik":"0001557928","reported_name":"Smith Julie","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option (right to buy)","published_at":"2024-06-05T00:19:28.000Z","date":"2024-05-31","kind":"grant","planned":false,"acquired":true,"shares":20030,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Option granted pursuant to the Exelixis, Inc. 2017 Equity Incentive Plan. The option is exercisable immediately, subject to repurchase provisions, and will vest as to 100% of the shares subject to the option on the one-year anniversary of the Transaction Date, subject to the Reporting Person's continuous service through such date."}],"balance_after":20030,"derivative":{"exercise_price":21.69,"exercise_date":"2024-05-31","expiration_date":"2031-05-30","underlying":"Common Stock","underlying_shares":20030},"source":{"system":"sec-edgar","filing":"0000939767-24-000094","document":"wk-form4_1717546761.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/939767/000093976724000094/wk-form4_1717546761.xml","form_type":"4"}},{"id":1493555,"issuer":{"id":3386,"kind":"organization","name":"EXELIXIS, INC."},"owners":[{"id":40913,"kind":"person","name":"Smith Julie","position":1,"cik":"0001557928","reported_name":"Smith Julie","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-06-05T00:19:28.000Z","date":"2024-05-31","kind":"grant","planned":false,"acquired":true,"shares":10015,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"Represents restricted stock units (\"RSUs\") granted to the Reporting Person on the Transaction Date pursuant to the Exelixis, Inc. 2017 Equity Incentive Plan. The RSUs will vest as to 100% of the shares subject to the RSU award on May 31, 2025, subject to the Reporting Person's continuous service through that date."},{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock units (\"RSUs\") granted to the Reporting Person on the Transaction Date pursuant to the Exelixis, Inc. 2017 Equity Incentive Plan. The RSUs will vest as to 100% of the shares subject to the RSU award on May 31, 2025, subject to the Reporting Person's continuous service through that date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 10,015 shares of Exelixis, Inc. common stock that will be issued to the Reporting Person upon vesting of RSUs. Each RSU is the economic equivalent of one share of Exelixis, Inc. common stock."}],"balance_after":15460,"source":{"system":"sec-edgar","filing":"0000939767-24-000094","document":"wk-form4_1717546761.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/939767/000093976724000094/wk-form4_1717546761.xml","form_type":"4"}},{"id":1504377,"issuer":{"id":3386,"kind":"organization","name":"EXELIXIS, INC."},"owners":[{"id":40913,"kind":"person","name":"Smith Julie","position":1,"cik":"0001557928","reported_name":"Smith Julie","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-05-23T22:55:42.000Z","date":"2024-05-21","kind":"sale","planned":false,"acquired":false,"shares":27280,"price":21.12,"value":576153.6,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $21.11 to $21.17. Reporting Person undertakes to provide Exelixis, Inc., any security holder of Exelixis, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote 1 to this Form 4."}],"balance_after":5445,"source":{"system":"sec-edgar","filing":"0000939767-24-000077","document":"wk-form4_1716504931.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/939767/000093976724000077/wk-form4_1716504931.xml","form_type":"4"}},{"id":1854287,"issuer":{"id":1723,"kind":"organization","name":"Stoke Therapeutics, Inc.","symbol":"STOK"},"owners":[{"id":40913,"kind":"person","name":"Smith Julie","position":1,"cik":"0001557928","reported_name":"Smith Julie","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Option (Right to Buy)","published_at":"2023-06-15T22:26:12.000Z","date":"2023-06-13","kind":"grant","planned":false,"acquired":true,"shares":19441,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option shall fully vest on June 13, 2024 or, if earlier, the next annual meeting of the issuer's stockholders, subject to the reporting holder's continued service on such vesting date."}],"balance_after":19441,"derivative":{"exercise_price":12.46,"expiration_date":"2033-06-12","underlying":"Common Stock","underlying_shares":19441},"source":{"system":"sec-edgar","filing":"0001209191-23-037537","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1623526/000120919123037537/doc4.xml","form_type":"4"}},{"id":1870847,"issuer":{"id":3386,"kind":"organization","name":"EXELIXIS, INC."},"owners":[{"id":40913,"kind":"person","name":"Smith Julie","position":1,"cik":"0001557928","reported_name":"Smith Julie","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option (right to buy)","published_at":"2023-06-03T01:10:35.000Z","date":"2023-06-01","kind":"grant","planned":false,"acquired":true,"shares":44087,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Option granted pursuant to the Exelixis, Inc. 2017 Equity Incentive Plan. The option is exercisable immediately, subject to repurchase provisions, and will vest as to 100% of the shares subject to the option on the first anniversary of the date of grant, subject to the Reporting Person's continuous service through such date."}],"balance_after":44087,"derivative":{"exercise_price":19.39,"exercise_date":"2023-06-01","expiration_date":"2030-05-31","underlying":"Common Stock","underlying_shares":44087},"source":{"system":"sec-edgar","filing":"0000939767-23-000055","document":"wk-form4_1685754626.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/939767/000093976723000055/wk-form4_1685754626.xml","form_type":"4"}},{"id":2239115,"issuer":{"id":1723,"kind":"organization","name":"Stoke Therapeutics, Inc.","symbol":"STOK"},"owners":[{"id":40913,"kind":"person","name":"Smith Julie","position":1,"cik":"0001557928","reported_name":"Smith Julie","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Option (Right to Buy)","published_at":"2022-06-08T21:00:21.000Z","date":"2022-06-07","kind":"grant","acquired":true,"shares":21000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option shall vest on June 7, 2023 or, if earlier, the next annual meeting of the issuer's stockholders, subject to the reporting holder's continued service on such vesting date."}],"balance_after":21000,"derivative":{"exercise_price":12.96,"expiration_date":"2032-06-06","underlying":"Common Stock","underlying_shares":21000},"source":{"system":"sec-edgar","filing":"0001209191-22-035074","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1623526/000120919122035074/doc4.xml","form_type":"4"}},{"id":2254246,"issuer":{"id":3386,"kind":"organization","name":"EXELIXIS, INC."},"owners":[{"id":40913,"kind":"person","name":"Smith Julie","position":1,"cik":"0001557928","reported_name":"Smith Julie","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option (right to buy)","published_at":"2022-05-28T01:12:44.000Z","date":"2022-05-26","kind":"grant","acquired":true,"shares":42422,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Option granted pursuant to the Exelixis, Inc. 2017 Equity Incentive Plan. The option is exercisable immediately, subject to repurchase provisions, and will vest as to 100% of the shares subject to the option on the first anniversary of the date of grant, subject to the Reporting Person's continuous service through such date."}],"balance_after":42422,"derivative":{"exercise_price":18.19,"exercise_date":"2022-05-26","expiration_date":"2029-05-25","underlying":"Common Stock","underlying_shares":42422},"source":{"system":"sec-edgar","filing":"0000939767-22-000077","document":"wf-form4_165370034166320.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/939767/000093976722000077/wf-form4_165370034166320.xml","form_type":"4"}},{"id":2654765,"issuer":{"id":1723,"kind":"organization","name":"Stoke Therapeutics, Inc.","symbol":"STOK"},"owners":[{"id":40913,"kind":"person","name":"Smith Julie","position":1,"cik":"0001557928","reported_name":"Smith Julie","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Option (Right to Buy)","published_at":"2021-06-25T21:02:34.000Z","date":"2021-06-08","kind":"grant","acquired":true,"shares":11650,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option shall fully vest on June 8, 2022 or, if earlier, the next annual meeting of the issuer's stockholders, subject to the reporting holder's  continued service on such  vesting date."}],"balance_after":11650,"derivative":{"exercise_price":40.37,"expiration_date":"2031-06-07","underlying":"Common Stock","underlying_shares":11650},"source":{"system":"sec-edgar","filing":"0001209191-21-043338","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1623526/000120919121043338/doc4.xml","form_type":"4"}},{"id":2691940,"issuer":{"id":3386,"kind":"organization","name":"EXELIXIS, INC."},"owners":[{"id":40913,"kind":"person","name":"Smith Julie","position":1,"cik":"0001557928","reported_name":"Smith Julie","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-05-29T00:08:51.000Z","date":"2021-05-27","kind":"grant","acquired":true,"shares":16424,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents shares of Exelixis, Inc. common stock issued to the Reporting Person upon vesting of restricted stock units. Each restricted stock unit is the economic equivalent of one share of Exelixis, Inc. common stock."},{"field":"date","element":"transactionDate","label":"F2","text":"The restricted stock units were granted to the Reporting Person on the Transaction Date pursuant to the Exelixis, Inc. 2017 Equity Incentive Plan.  The restricted stock units will vest as to 100% of the shares subject to the restricted stock unit award on May 27, 2022, subject to the Reporting Person's continuous service through that date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 16,424 shares of Exelixis, Inc. common stock that will be issued to the Reporting Person upon vesting of restricted stock units."}],"balance_after":32725,"source":{"system":"sec-edgar","filing":"0000939767-21-000058","document":"wf-form4_162224691723172.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/939767/000093976721000058/wf-form4_162224691723172.xml","form_type":"4"}},{"id":3120384,"issuer":{"id":1723,"kind":"organization","name":"Stoke Therapeutics, Inc.","symbol":"STOK"},"owners":[{"id":40913,"kind":"person","name":"Smith Julie","position":1,"cik":"0001557928","reported_name":"Smith Julie","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Option (Right to Buy)","published_at":"2020-06-05T21:31:31.000Z","date":"2020-06-03","kind":"grant","acquired":true,"shares":29555,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests as to 1/12th of the total shares on September 3, 2020, and then 1/12th of the total shares vest quarterly thereafter, subject to the  reporting person's continued service to the issuer through each vesting date."}],"balance_after":29555,"derivative":{"exercise_price":26.53,"expiration_date":"2020-06-02","underlying":"Common Stock","underlying_shares":29555},"source":{"system":"sec-edgar","filing":"0001209191-20-034735","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1623526/000120919120034735/doc4.xml","form_type":"4"}},{"id":3137988,"issuer":{"id":3386,"kind":"organization","name":"EXELIXIS, INC."},"owners":[{"id":40913,"kind":"person","name":"Smith Julie","position":1,"cik":"0001557928","reported_name":"Smith Julie","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-05-23T01:06:18.000Z","date":"2020-05-21","kind":"grant","acquired":true,"shares":15538,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents shares of Exelixis, Inc. common stock that will be issued to the Reporting Person upon vesting of restricted stock units.  Each restricted stock unit is the economic equivalent of one share of Exelixis, Inc. common stock."},{"field":"date","element":"transactionDate","label":"F2","text":"The restricted stock units were granted to the Reporting Person on the Transaction Date pursuant to the Exelixis, Inc. 2017 Equity Incentive Plan.  The restricted stock units will vest as to 100% of the shares subject to the restricted stock unit award on May 21, 2021, subject to the Reporting Person's continuous service through that date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 15,538 shares of Exelixis, Inc. common stock that will be issued to the Reporting Person upon vesting of restricted stock units."}],"balance_after":16301,"source":{"system":"sec-edgar","filing":"0000939767-20-000098","document":"wf-form4_159019595983746.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/939767/000093976720000098/wf-form4_159019595983746.xml","form_type":"4"}},{"id":3310849,"issuer":{"id":122788,"kind":"organization","name":"Audentes Therapeutics, Inc."},"owners":[{"id":40913,"kind":"person","name":"Smith Julie","position":1,"cik":"0001557928","reported_name":"Smith Julie","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2020-01-15T13:37:34.000Z","date":"2020-01-15","kind":"disposition_to_issuer","acquired":false,"shares":16200,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On December 2, 2019, Audentes Therapeutics, Inc. (the \"Company\") entered into an Agreement and Plan of Merger (as it may be amended, supplemented or otherwise modified from time to time, the \"Merger Agreement\") with Astellas Pharma Inc. (\"Astellas\") and Asilomar Acquisition Corp., a wholly-owned subsidiary of Astellas (\"Merger Sub\"), pursuant to which Astellas acquired the Company by a tender offer for all shares of Company common stock (the \"Offer\") and a subsequent merger (the \"Merger\"), each of which became effective on January 15, 2020. Pursuant to the Merger Agreement, (i) Merger Sub purchased all shares of Company common stock that were validly tendered pursuant to the Offer for a cash payment equal to $60.00 per share (the \"Offer Price\") and (ii) all shares of Company common stock outstanding immediately prior to the effective time of the Merger (the \"Effective Time\"), were canceled and converted automatically into the right to receive the Offer Price."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Pursuant to the Merger Agreement, immediately prior to the Effective Time, all outstanding Company stock options, to the extent unvested, became fully vested, and at the Effective Time, each outstanding Company stock option was cancelled and converted into the right to receive an amount of cash (subject to any applicable withholding or other taxes required by applicable law) determined by multiplying (i) the number of shares of Company common stock subject to such stock option immediately prior to such cancellation by (ii) the excess, if any, of an amount in cash equal to the Offer Price, without any interest, over the exercise price per share of Company common stock subject to such stock option, less any applicable tax withholding. Any such option that had an exercise price that equaled or exceeded the Offer Price was cancelled for no consideration."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Pursuant to the Merger Agreement, immediately prior to the Effective Time, all outstanding Company stock options, to the extent unvested, became fully vested, and at the Effective Time, each outstanding Company stock option was cancelled and converted into the right to receive an amount of cash (subject to any applicable withholding or other taxes required by applicable law) determined by multiplying (i) the number of shares of Company common stock subject to such stock option immediately prior to such cancellation by (ii) the excess, if any, of an amount in cash equal to the Offer Price, without any interest, over the exercise price per share of Company common stock subject to such stock option, less any applicable tax withholding. Any such option that had an exercise price that equaled or exceeded the Offer Price was cancelled for no consideration."}],"balance_after":0,"derivative":{"exercise_price":24.74,"expiration_date":"2029-02-06","underlying":"Common Stock","underlying_shares":16200},"source":{"system":"sec-edgar","filing":"0001209191-20-003436","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1628738/000120919120003436/doc4.xml","form_type":"4"}},{"id":3310848,"issuer":{"id":122788,"kind":"organization","name":"Audentes Therapeutics, Inc."},"owners":[{"id":40913,"kind":"person","name":"Smith Julie","position":1,"cik":"0001557928","reported_name":"Smith Julie","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2020-01-15T13:37:34.000Z","date":"2020-01-15","kind":"disposition_to_issuer","acquired":false,"shares":10000,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On December 2, 2019, Audentes Therapeutics, Inc. (the \"Company\") entered into an Agreement and Plan of Merger (as it may be amended, supplemented or otherwise modified from time to time, the \"Merger Agreement\") with Astellas Pharma Inc. (\"Astellas\") and Asilomar Acquisition Corp., a wholly-owned subsidiary of Astellas (\"Merger Sub\"), pursuant to which Astellas acquired the Company by a tender offer for all shares of Company common stock (the \"Offer\") and a subsequent merger (the \"Merger\"), each of which became effective on January 15, 2020. Pursuant to the Merger Agreement, (i) Merger Sub purchased all shares of Company common stock that were validly tendered pursuant to the Offer for a cash payment equal to $60.00 per share (the \"Offer Price\") and (ii) all shares of Company common stock outstanding immediately prior to the effective time of the Merger (the \"Effective Time\"), were canceled and converted automatically into the right to receive the Offer Price."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Pursuant to the Merger Agreement, immediately prior to the Effective Time, all outstanding Company stock options, to the extent unvested, became fully vested, and at the Effective Time, each outstanding Company stock option was cancelled and converted into the right to receive an amount of cash (subject to any applicable withholding or other taxes required by applicable law) determined by multiplying (i) the number of shares of Company common stock subject to such stock option immediately prior to such cancellation by (ii) the excess, if any, of an amount in cash equal to the Offer Price, without any interest, over the exercise price per share of Company common stock subject to such stock option, less any applicable tax withholding. Any such option that had an exercise price that equaled or exceeded the Offer Price was cancelled for no consideration."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Pursuant to the Merger Agreement, immediately prior to the Effective Time, all outstanding Company stock options, to the extent unvested, became fully vested, and at the Effective Time, each outstanding Company stock option was cancelled and converted into the right to receive an amount of cash (subject to any applicable withholding or other taxes required by applicable law) determined by multiplying (i) the number of shares of Company common stock subject to such stock option immediately prior to such cancellation by (ii) the excess, if any, of an amount in cash equal to the Offer Price, without any interest, over the exercise price per share of Company common stock subject to such stock option, less any applicable tax withholding. Any such option that had an exercise price that equaled or exceeded the Offer Price was cancelled for no consideration."}],"balance_after":0,"derivative":{"exercise_price":38.65,"expiration_date":"2028-06-08","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001209191-20-003436","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1628738/000120919120003436/doc4.xml","form_type":"4"}},{"id":3310847,"issuer":{"id":122788,"kind":"organization","name":"Audentes Therapeutics, Inc."},"owners":[{"id":40913,"kind":"person","name":"Smith Julie","position":1,"cik":"0001557928","reported_name":"Smith Julie","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2020-01-15T13:37:34.000Z","date":"2020-01-15","kind":"disposition_to_issuer","acquired":false,"shares":9000,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Reflects the correct exercise price of this option.  The exercise price of this option was previously reported as $26.01."},{"field":"kind","element":"transactionCoding","label":"F1","text":"On December 2, 2019, Audentes Therapeutics, Inc. (the \"Company\") entered into an Agreement and Plan of Merger (as it may be amended, supplemented or otherwise modified from time to time, the \"Merger Agreement\") with Astellas Pharma Inc. (\"Astellas\") and Asilomar Acquisition Corp., a wholly-owned subsidiary of Astellas (\"Merger Sub\"), pursuant to which Astellas acquired the Company by a tender offer for all shares of Company common stock (the \"Offer\") and a subsequent merger (the \"Merger\"), each of which became effective on January 15, 2020. Pursuant to the Merger Agreement, (i) Merger Sub purchased all shares of Company common stock that were validly tendered pursuant to the Offer for a cash payment equal to $60.00 per share (the \"Offer Price\") and (ii) all shares of Company common stock outstanding immediately prior to the effective time of the Merger (the \"Effective Time\"), were canceled and converted automatically into the right to receive the Offer Price."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Pursuant to the Merger Agreement, immediately prior to the Effective Time, all outstanding Company stock options, to the extent unvested, became fully vested, and at the Effective Time, each outstanding Company stock option was cancelled and converted into the right to receive an amount of cash (subject to any applicable withholding or other taxes required by applicable law) determined by multiplying (i) the number of shares of Company common stock subject to such stock option immediately prior to such cancellation by (ii) the excess, if any, of an amount in cash equal to the Offer Price, without any interest, over the exercise price per share of Company common stock subject to such stock option, less any applicable tax withholding. Any such option that had an exercise price that equaled or exceeded the Offer Price was cancelled for no consideration."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Pursuant to the Merger Agreement, immediately prior to the Effective Time, all outstanding Company stock options, to the extent unvested, became fully vested, and at the Effective Time, each outstanding Company stock option was cancelled and converted into the right to receive an amount of cash (subject to any applicable withholding or other taxes required by applicable law) determined by multiplying (i) the number of shares of Company common stock subject to such stock option immediately prior to such cancellation by (ii) the excess, if any, of an amount in cash equal to the Offer Price, without any interest, over the exercise price per share of Company common stock subject to such stock option, less any applicable tax withholding. Any such option that had an exercise price that equaled or exceeded the Offer Price was cancelled for no consideration."}],"balance_after":0,"derivative":{"exercise_price":26.15,"expiration_date":"2027-10-08","underlying":"Common Stock","underlying_shares":9000},"source":{"system":"sec-edgar","filing":"0001209191-20-003436","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1628738/000120919120003436/doc4.xml","form_type":"4"}},{"id":3310846,"issuer":{"id":122788,"kind":"organization","name":"Audentes Therapeutics, Inc."},"owners":[{"id":40913,"kind":"person","name":"Smith Julie","position":1,"cik":"0001557928","reported_name":"Smith Julie","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2020-01-15T13:37:34.000Z","date":"2020-01-15","kind":"disposition_to_issuer","acquired":false,"shares":18000,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On December 2, 2019, Audentes Therapeutics, Inc. (the \"Company\") entered into an Agreement and Plan of Merger (as it may be amended, supplemented or otherwise modified from time to time, the \"Merger Agreement\") with Astellas Pharma Inc. (\"Astellas\") and Asilomar Acquisition Corp., a wholly-owned subsidiary of Astellas (\"Merger Sub\"), pursuant to which Astellas acquired the Company by a tender offer for all shares of Company common stock (the \"Offer\") and a subsequent merger (the \"Merger\"), each of which became effective on January 15, 2020. Pursuant to the Merger Agreement, (i) Merger Sub purchased all shares of Company common stock that were validly tendered pursuant to the Offer for a cash payment equal to $60.00 per share (the \"Offer Price\") and (ii) all shares of Company common stock outstanding immediately prior to the effective time of the Merger (the \"Effective Time\"), were canceled and converted automatically into the right to receive the Offer Price."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Pursuant to the Merger Agreement, immediately prior to the Effective Time, all outstanding Company stock options, to the extent unvested, became fully vested, and at the Effective Time, each outstanding Company stock option was cancelled and converted into the right to receive an amount of cash (subject to any applicable withholding or other taxes required by applicable law) determined by multiplying (i) the number of shares of Company common stock subject to such stock option immediately prior to such cancellation by (ii) the excess, if any, of an amount in cash equal to the Offer Price, without any interest, over the exercise price per share of Company common stock subject to such stock option, less any applicable tax withholding. Any such option that had an exercise price that equaled or exceeded the Offer Price was cancelled for no consideration."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Pursuant to the Merger Agreement, immediately prior to the Effective Time, all outstanding Company stock options, to the extent unvested, became fully vested, and at the Effective Time, each outstanding Company stock option was cancelled and converted into the right to receive an amount of cash (subject to any applicable withholding or other taxes required by applicable law) determined by multiplying (i) the number of shares of Company common stock subject to such stock option immediately prior to such cancellation by (ii) the excess, if any, of an amount in cash equal to the Offer Price, without any interest, over the exercise price per share of Company common stock subject to such stock option, less any applicable tax withholding. Any such option that had an exercise price that equaled or exceeded the Offer Price was cancelled for no consideration."}],"balance_after":0,"derivative":{"exercise_price":17.85,"expiration_date":"2027-01-01","underlying":"Common Stock","underlying_shares":18000},"source":{"system":"sec-edgar","filing":"0001209191-20-003436","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1628738/000120919120003436/doc4.xml","form_type":"4"}},{"id":3512505,"issuer":{"id":3386,"kind":"organization","name":"EXELIXIS, INC."},"owners":[{"id":40913,"kind":"person","name":"Smith Julie","position":1,"cik":"0001557928","reported_name":"Smith Julie","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option (right to buy)","published_at":"2019-05-25T00:47:38.000Z","date":"2019-05-23","kind":"grant","acquired":true,"shares":42641,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Option granted pursuant to the Exelixis, Inc. 2017 Equity Incentive Plan. The option is exercisable immediately, subject to repurchase provisions, and will vest as to 100% of the shares subject to the option on the first anniversary of the date of grant, subject to the Reporting Person's continuous service through such date."}],"balance_after":42641,"derivative":{"exercise_price":19.77,"exercise_date":"2019-05-23","expiration_date":"2026-05-22","underlying":"Common Stock","underlying_shares":42641},"source":{"system":"sec-edgar","filing":"0000939767-19-000136","document":"wf-form4_155874524378443.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/939767/000093976719000136/wf-form4_155874524378443.xml","form_type":"4"}},{"id":3668146,"issuer":{"id":122788,"kind":"organization","name":"Audentes Therapeutics, Inc."},"owners":[{"id":40913,"kind":"person","name":"Smith Julie","position":1,"cik":"0001557928","reported_name":"Smith Julie","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2019-02-08T17:28:12.000Z","date":"2019-02-06","kind":"grant","acquired":true,"shares":16200,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests as to 100% of the shares upon the earlier of (i) the one-year anniversary of the grant date, and (ii) a Corporate Transaction of the Company as defined in the Company's 2016 Equity Incentive Plan; subject to the reporting person's continued service to the Company on the vesting date."}],"balance_after":16200,"derivative":{"exercise_price":24.74,"expiration_date":"2029-02-06","underlying":"Common Stock","underlying_shares":16200},"source":{"system":"sec-edgar","filing":"0001209191-19-008676","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1628738/000120919119008676/doc4.xml","form_type":"4"}},{"id":3900052,"issuer":{"id":122788,"kind":"organization","name":"Audentes Therapeutics, Inc."},"owners":[{"id":40913,"kind":"person","name":"Smith Julie","position":1,"cik":"0001557928","reported_name":"Smith Julie","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2018-06-08T17:24:24.000Z","date":"2018-06-08","kind":"grant","acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests as to 100% of the shares upon the earliest of (i) the Company's 2019 annual meeting of stockholders, (ii) the one-year anniversary of the grant date, and (iii) a Corporate Transaction of the Company as defined in the Company's 2016 Equity Incentive Plan; subject to the reporting person's continued service to the Company on the vesting date."}],"balance_after":10000,"derivative":{"exercise_price":38.65,"expiration_date":"2028-06-08","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001209191-18-036743","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1628738/000120919118036743/doc4.xml","form_type":"4"}},{"id":3919298,"issuer":{"id":3386,"kind":"organization","name":"EXELIXIS, INC."},"owners":[{"id":40913,"kind":"person","name":"Smith Julie","position":1,"cik":"0001557928","reported_name":"Smith Julie","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option (right to buy)","published_at":"2018-05-25T00:30:34.000Z","date":"2018-05-24","kind":"grant","acquired":true,"shares":31167,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Option granted pursuant to the Exelixis, Inc. 2017 Equity Incentive Plan. The option is exercisable immediately, subject to repurchase provisions, and will vest as to 1/12th of the shares subject to the option each month following the date of grant, subject to the Reporting Person's continuous service through such dates."}],"balance_after":31167,"derivative":{"exercise_price":20.5,"exercise_date":"2018-05-24","expiration_date":"2025-05-23","underlying":"Common Stock","underlying_shares":31167},"source":{"system":"sec-edgar","filing":"0000939767-18-000110","document":"wf-form4_152720822079492.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/939767/000093976718000110/wf-form4_152720822079492.xml","form_type":"4"}},{"id":4189163,"issuer":{"id":122788,"kind":"organization","name":"Audentes Therapeutics, Inc."},"owners":[{"id":40913,"kind":"person","name":"Smith Julie","position":1,"cik":"0001557928","reported_name":"Smith Julie","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2017-10-10T18:07:35.000Z","date":"2017-10-08","kind":"grant","acquired":true,"shares":9000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests as to 100% of the shares upon the earliest of (i) the Company's 2018 annual meeting of stockholders, (ii) the one-year anniversary of the grant date, and (iii) a Corporate Transaction of the Company as defined in the Company's 2016 Equity Incentive Plan; subject to the reporting person's continued service to the Company on the vesting date."}],"balance_after":9000,"derivative":{"exercise_price":26.01,"expiration_date":"2027-10-08","underlying":"Common Stock","underlying_shares":9000},"source":{"system":"sec-edgar","filing":"0001209191-17-056532","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1628738/000120919117056532/doc4.xml","form_type":"4"}},{"id":4303691,"issuer":{"id":3386,"kind":"organization","name":"EXELIXIS, INC."},"owners":[{"id":40913,"kind":"person","name":"Smith Julie","position":1,"cik":"0001557928","reported_name":"Smith Julie","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option (right to buy)","published_at":"2017-05-27T00:53:36.000Z","date":"2017-05-25","kind":"grant","acquired":true,"shares":23491,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Option granted pursuant to the Exelixis, Inc. 2017 Equity Incentive Plan. The option is exercisable immediately, subject to repurchase provisions, and will vest as to 1/12th of the shares subject to the option each month following the date of grant, subject to the Reporting Person's continuous service through such dates."}],"balance_after":23491,"derivative":{"exercise_price":19.57,"exercise_date":"2017-05-25","expiration_date":"2024-05-24","underlying":"Common Stock","underlying_shares":23491},"source":{"system":"sec-edgar","filing":"0000939767-17-000117","document":"wf-form4_149584640178321.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/939767/000093976717000117/wf-form4_149584640178321.xml","form_type":"4"}},{"id":4425518,"issuer":{"id":3386,"kind":"organization","name":"EXELIXIS, INC."},"owners":[{"id":40913,"kind":"person","name":"Smith Julie","position":1,"cik":"0001557928","reported_name":"Smith Julie","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option (right to buy)","published_at":"2017-02-25T02:00:23.000Z","date":"2017-02-23","kind":"grant","acquired":true,"shares":16620,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Option granted pursuant to the 2014 Plan. Option will vest as to 1/4th of the original number of shares subject to the option on the one-year anniversary of the Transaction Date, and thereafter as to 1/48th of the original number of shares subject to the option on each monthly anniversary of the Transaction Date."}],"balance_after":16620,"derivative":{"exercise_price":21.74,"exercise_date":"2018-02-23","expiration_date":"2024-02-22","underlying":"Common Stock","underlying_shares":16620},"source":{"system":"sec-edgar","filing":"0000939767-17-000014","document":"wf-form4_148798801033982.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/939767/000093976717000014/wf-form4_148798801033982.xml","form_type":"4"}},{"id":4498681,"issuer":{"id":122788,"kind":"organization","name":"Audentes Therapeutics, Inc."},"owners":[{"id":40913,"kind":"person","name":"Smith Julie","position":1,"cik":"0001557928","reported_name":"Smith Julie","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2017-01-05T18:15:35.000Z","date":"2017-01-01","kind":"grant","acquired":true,"shares":18000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests as to 2.777% of the total shares monthly, beginning January 12, 2017, with 100% of the total shares vested and exercisable on December 12, 2019, subject to the reporting person's provision of service to the issuer on each vesting date."}],"balance_after":18000,"derivative":{"exercise_price":17.85,"expiration_date":"2027-01-01","underlying":"Common Stock","underlying_shares":18000},"source":{"system":"sec-edgar","filing":"0001209191-17-002317","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1628738/000120919117002317/doc4.xml","form_type":"4"}},{"id":4574217,"issuer":{"id":181476,"kind":"organization","name":"Raptor Pharmaceutical Corp","symbol":"RPTP"},"owners":[{"id":40913,"kind":"person","name":"Smith Julie","position":1,"cik":"0001557928","reported_name":"Smith Julie","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option(right to buy)","published_at":"2016-10-26T16:38:20.000Z","date":"2016-10-25","kind":"disposition_to_issuer","acquired":false,"shares":240595,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Pursuant to the Merger Agreement, on October 25, 2016, each outstanding stock option was accelerated in full and cancelled in exchange for the right to receive $9.00 in cash, without interest and less the exercise price of such option and any required withholding taxes."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Pursuant to the Merger Agreement, on October 25, 2016, each outstanding stock option was accelerated in full and cancelled in exchange for the right to receive $9.00 in cash, without interest and less the exercise price of such option and any required withholding taxes."}],"balance_after":0,"derivative":{"exercise_price":3.74,"expiration_date":"2026-02-09","underlying":"Common Stock","underlying_shares":240595},"source":{"system":"sec-edgar","filing":"0001140361-16-083647","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1070698/000114036116083647/doc1.xml","form_type":"4"}},{"id":4574216,"issuer":{"id":181476,"kind":"organization","name":"Raptor Pharmaceutical Corp","symbol":"RPTP"},"owners":[{"id":40913,"kind":"person","name":"Smith Julie","position":1,"cik":"0001557928","reported_name":"Smith Julie","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option(right to buy)","published_at":"2016-10-26T16:38:20.000Z","date":"2016-10-25","kind":"disposition_to_issuer","acquired":false,"shares":175000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Pursuant to the Merger Agreement, on October 25, 2016, each outstanding stock option was accelerated in full and cancelled in exchange for the right to receive $9.00 in cash, without interest and less the exercise price of such option and any required withholding taxes."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Pursuant to the Merger Agreement, on October 25, 2016, each outstanding stock option was accelerated in full and cancelled in exchange for the right to receive $9.00 in cash, without interest and less the exercise price of such option and any required withholding taxes."}],"balance_after":0,"derivative":{"exercise_price":8.13,"expiration_date":"2024-07-29","underlying":"Common Stock","underlying_shares":175000},"source":{"system":"sec-edgar","filing":"0001140361-16-083647","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1070698/000114036116083647/doc1.xml","form_type":"4"}},{"id":4574215,"issuer":{"id":181476,"kind":"organization","name":"Raptor Pharmaceutical Corp","symbol":"RPTP"},"owners":[{"id":40913,"kind":"person","name":"Smith Julie","position":1,"cik":"0001557928","reported_name":"Smith Julie","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option(right to buy)","published_at":"2016-10-26T16:38:20.000Z","date":"2016-10-25","kind":"disposition_to_issuer","acquired":false,"shares":152050,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Pursuant to the Merger Agreement, on October 25, 2016, each outstanding stock option was accelerated in full and cancelled in exchange for the right to receive $9.00 in cash, without interest and less the exercise price of such option and any required withholding taxes."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Pursuant to the Merger Agreement, on October 25, 2016, each outstanding stock option was accelerated in full and cancelled in exchange for the right to receive $9.00 in cash, without interest and less the exercise price of such option and any required withholding taxes."}],"balance_after":0,"derivative":{"exercise_price":5.27,"expiration_date":"2022-09-10","underlying":"Common Stock","underlying_shares":152050},"source":{"system":"sec-edgar","filing":"0001140361-16-083647","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1070698/000114036116083647/doc1.xml","form_type":"4"}},{"id":4574214,"issuer":{"id":181476,"kind":"organization","name":"Raptor Pharmaceutical Corp","symbol":"RPTP"},"owners":[{"id":40913,"kind":"person","name":"Smith Julie","position":1,"cik":"0001557928","reported_name":"Smith Julie","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2016-10-26T16:38:20.000Z","date":"2016-10-25","kind":"disposition_to_issuer","acquired":false,"shares":64179,"price":9,"value":577611.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Pursuant to the Merger Agreement, on October 25, 2016, each outstanding restricted stock unit was accelerated in full and cancelled in exchange for the right to receive $9.00 per share in cash, without interest and less any required withholding taxes."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001140361-16-083647","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1070698/000114036116083647/doc1.xml","form_type":"4"}},{"id":4574213,"issuer":{"id":181476,"kind":"organization","name":"Raptor Pharmaceutical Corp","symbol":"RPTP"},"owners":[{"id":40913,"kind":"person","name":"Smith Julie","position":1,"cik":"0001557928","reported_name":"Smith Julie","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2016-10-26T16:38:20.000Z","date":"2016-10-24","kind":"other","acquired":false,"shares":45759,"price":9,"value":411831.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares tendered in connection with an offer to purchase all of the issued and outstanding shares of common stock of Raptor Pharmaceutical Corp. (\"Raptor\"), par value $0.001 per share, for an amount of $9.00 per share in cash, without interest and less any applicable withholding taxes, commenced pursuant to the Agreement and Plan of Merger (the \"Merger Agreement\"), dated as of September 12, 2016, by and among Raptor, Horizon Pharma plc, a public limited company organized under the laws of Ireland (\"Parent\") and Misneach Corporation, a Delaware corporation and an indirect wholly owned subsidiary of Parent."}],"balance_after":64179,"source":{"system":"sec-edgar","filing":"0001140361-16-083647","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1070698/000114036116083647/doc1.xml","form_type":"4"}},{"id":4595371,"issuer":{"id":3386,"kind":"organization","name":"EXELIXIS, INC."},"owners":[{"id":40913,"kind":"person","name":"Smith Julie","position":1,"cik":"0001557928","reported_name":"Smith Julie","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option (right to buy)","published_at":"2016-09-26T21:31:05.000Z","date":"2016-09-22","kind":"grant","acquired":true,"shares":26000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Option granted pursuant to the 2014 Plan. Option will vest as to 1/4th of the original number of shares subject to the option on the one-year anniversary of the Transaction Date, and thereafter as to 1/48th of the original number of shares subject to the option on each monthly anniversary of the Transaction Date."}],"balance_after":26000,"derivative":{"exercise_price":14.74,"exercise_date":"2017-09-22","expiration_date":"2023-09-21","underlying":"Common Stock","underlying_shares":26000},"source":{"system":"sec-edgar","filing":"0000939767-16-000248","document":"wf-form4_147492545113245.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/939767/000093976716000248/wf-form4_147492545113245.xml","form_type":"4"}},{"id":4595370,"issuer":{"id":3386,"kind":"organization","name":"EXELIXIS, INC."},"owners":[{"id":40913,"kind":"person","name":"Smith Julie","position":1,"cik":"0001557928","reported_name":"Smith Julie","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2016-09-26T21:31:05.000Z","date":"2016-09-22","kind":"grant","acquired":true,"shares":763,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents shares of Exelixis, Inc. common stock that will be issued to the Reporting Person upon vesting of restricted stock units. Each restricted stock unit is the economic equivalent of one share of Exelixis, Inc. common stock."},{"field":"date","element":"transactionDate","label":"F2","text":"The restricted stock units were granted to the Reporting Person on the Transaction Date pursuant to the Exelixis, Inc. 2014 Equity Incentive Plan (the \"2014 Plan\"). The restricted stock units will vest in full on December 30, 2016."}],"balance_after":763,"source":{"system":"sec-edgar","filing":"0000939767-16-000248","document":"wf-form4_147492545113245.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/939767/000093976716000248/wf-form4_147492545113245.xml","form_type":"4"}}]}